We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current AGIO market cap is 3.1B. The company's latest EPS is USD -6.1737 and P/E is -8.84.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 7.4M | 7.1M | 8.19M | 8.62M | 8.96M |
| Operating Income | -100.9M | -106.28M | -92.07M | -105.82M | -102.81M |
| Net Income | -91.32M | -95.94M | -81.55M | -96.12M | 947.92M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 117.91M | 203.2M | 41.41M | 14.24M | 26.82M |
| Operating Income | -426.33M | -316.15M | -387.83M | -389.05M | -391.49M |
| Net Income | -411.47M | -327.37M | 1.6B | -231.8M | -352.09M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.01B | 937.12M | 849.71M | 773.06M | 1.79B |
| Total Liabilities | 120.42M | 126.1M | 105.79M | 112.55M | 165.12M |
| Total Equity | 886.84M | 811.02M | 743.92M | 660.51M | 1.63B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 890.74M | 852.95M | 1.44B | 1.24B | 937.12M |
| Total Liabilities | 250.21M | 453.45M | 145.76M | 137.9M | 126.1M |
| Total Equity | 640.53M | 399.5M | 1.29B | 1.1B | 811.02M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -223.57M | -296.06M | -99.87M | -172.46M | -256.67M |
| Investing | 144.06M | 239.58M | 124.56M | 161.81M | 412.6M |
| Financing | 4.59M | 5.43M | 5.86M | 6.96M | 9.6M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -370.62M | -290.76M | -407.32M | -309.48M | -296.06M |
| Investing | 91.44M | 75.75M | 1.25B | 243.26M | 239.58M |
| Financing | 289.61M | 261.52M | -765.77M | 2.35M | 5.43M |
| Market Cap | 3.1B |
| Price to Earnings Ratio | -8.84 |
| Price to Sales Ratio | 115.99 |
| Price to Cash Ratio | 35.27 |
| Price to Book Ratio | 3.84 |
| Dividend Yield | - |
| Shares Outstanding | 57.03M |
| Average Volume (1 week) | 642.01k |
| Average Volume (1 Month) | 737.03k |
| 52 Week Change | 150.18% |
| 52 Week High | 62.58 |
| 52 Week Low | 20.96 |
| Spread (Intraday) | 0.19 (0.35%) |
| Company Name | Agios Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.agios.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
